Different disease modifying therapies can increase or decrease Covid-19 severity in Multiple Sclerosis

被引：0
|
作者：
Sormani, Maria Pia [1 ]
De Rossi, Nicola [2 ]
Schiavetti, Irene [1 ]
Carmisciano, Luca [1 ]
Cordioli, Cinzia [2 ]
Moiola, Lucia [3 ]
Radaelli, Marta [4 ,5 ]
Immovilli, Paolo [6 ]
Capobianco, Marco [7 ]
Trojano, Maria [8 ]
Zaratin, Paola [9 ]
Tedeschi, Gioacchino [10 ]
Comi, Giancarlo [11 ]
Battaglia, Mario Alberto [9 ]
Patti, Francesco [12 ]
Salvetti, Marco [13 ]
机构：
[1] Univ Genoa, Dept Hlth Sci, Genoa, Italy
[2] ASST Spedali Civili Brescia, Ctr Sclerosi Multipla, Brescia, Italy
[3] IRCCS Osped San Raffaele, Dept Neurol, Multiple Sclerosis Ctr, Milan, Italy
[4] ASST Papa Giovanni XXIII, Dept Neurol, Bergamo, Italy
[5] ASST Papa Giovanni XXIII, Multiple Sclerosis Ctr, Bergamo, Italy
[6] Osped Guglielmo Saliceto, Multiple Sclerosis Ctr, Piacenza, Italy
[7] Univ Hosp San Luigi, Dept Neurol, Reg Referral Multiple Sclerosis, Orbassano, Italy
[8] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
[9] Italian Multiple Sclerosis Fdn, Res Dept, Genoa, Italy
[10] Univ Campania, Dept Adv Med & Surg Sci, Naples, Italy
[11] IRCCS Osped San Raffaele, Inst Expt Neurol, Milan, Italy
[12] Univ Catania, Policlin Catania, Ctr Sclerosi Multipla, Catania, Italy
[13] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2021
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination
    Orru, Valeria
    Serra, Valentina
    Marongiu, Michele
    Lai, Sandra
    Lodde, Valeria
    Zoledziewska, Magdalena
    Steri, Maristella
    Loizedda, Annalisa
    Lobina, Monia
    Piras, Maria Grazia
    Virdis, Francesca
    Delogu, Giuseppe
    Marini, Maria Giuseppina
    Mingoia, Maura
    Floris, Matteo
    Masala, Marco
    Castelli, M. Paola
    Mostallino, Rafaela
    Frau, Jessica
    Lorefice, Lorena
    Farina, Gabriele
    Fronza, Marzia
    Carmagnini, Daniele
    Carta, Elisa
    Pilotto, Silvy
    Chessa, Paola
    Devoto, Marcella
    Castiglia, Paolo
    Solla, Paolo
    Zarbo, Roberto Ignazio
    Idda, Maria Laura
    Pitzalis, Maristella
    Cocco, Eleonora
    Fiorillo, Edoardo
    Cucca, Francesco
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies
    Baba, Cavid
    Ozcelik, Sinem
    Kaya, Ergi
    Samedzada, Ulvi
    Ozdogar, Asiye Tuba
    Cevik, Sumeyye
    Dogan, Yavuz
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [23] Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis
    Barzegar, Mahdi
    Houshi, Shakiba
    Sadeghi, Erfan
    Hashemi, Mozhgan Sadat
    Pishgahi, Ghasem
    Bagherieh, Sara
    Afshari-Safavi, Alireza
    Mirmosayyeb, Omid
    Shaygannejad, Vahid
    Zabeti, Aram
    MULTIPLE SCLEROSIS INTERNATIONAL, 2022, 2022
  • [24] Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies
    Habek, Mario
    Zeljko, Cvetic
    Mlakar, Ana Savic
    Bendelja, Kreso
    Rogic, Dunja
    Adamec, Ivan
    Barun, Barbara
    Gabelic, Tereza
    Skoric, Magdalena Krbot
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 59
  • [25] Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review
    Jamali, Elham
    Shapoori, Shima
    Farrokhi, Majid Reza
    Vakili, Sina
    Rostamzadeh, Davoud
    Iravanpour, Farideh
    Oliaee, Razieh Tavakoli
    Jafarinia, Morteza
    VIRAL IMMUNOLOGY, 2023, 36 (06) : 368 - 377
  • [26] Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
    Moehn, Nora
    Konen, Franz E.
    Pul, Refik
    Kleinschnitz, Christoph
    Pruss, Harald
    Witte, Torsten
    Stangel, Martin
    Skripuletz, Thomas
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 12
  • [27] Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
    Beesley, R.
    Cauchi, M.
    Davies, L.
    Upcott, M.
    Norton, E.
    Loveless, S.
    Anderson, V.
    Wynford-Thomas, R.
    Pickersgill, T. P.
    Uzochukwu, E.
    Wardle, M.
    Robertson, N. P.
    Tallantyre, E.
    Willis, M. D.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [28] Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies
    Spierer, Ronen
    Lavi, Idit
    Bloch, Sivan
    Mazar, Marianna
    Golan, Daniel
    JOURNAL OF NEUROLOGY, 2023, 270 (10) : 4632 - 4639
  • [29] The Impact of Disease-Modifying Therapies of Multiple Sclerosis on the Effectiveness of the BBIBP-CorV COVID-19 Vaccine
    Ghaffari, Mehran
    Moghadam, Nahid Beladi
    Paybast, Sepideh
    Aghamiri, Seyed Hossein
    Haghighi, Mehrdad
    Javadi, Abdolreza
    Rafatpanah, Houshang
    Le, Saba Sadeghi Rashed
    Nahayati, Mohammad Ali
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2024, 19 (06):
  • [30] Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis
    Etemadifar, Masoud
    Nouri, Hosein
    Pitzalis, Maristella
    Idda, Maria Laura
    Salari, Mehri
    Baratian, Mahshid
    Mahdavi, Sepide
    Abhari, Amir Parsa
    Sedaghat, Nahad
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09): : 986 - 994
12345